Sulfatide Inhibits HIV-1 Entry into CD4−/CXCR4+Cells
- 1 July 1998
- Vol. 246 (2) , 211-220
- https://doi.org/10.1006/viro.1998.9216
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- A new classification for HIV-1Nature, 1998
- Interaction of human immunodeficiency virus type 1 envelope protein with liposomes containing galactosylceramidePerspectives in Drug Discovery and Design, 1996
- HIV-1 infection of a CD4-negative primary cell type: The oligodendrocytePerspectives in Drug Discovery and Design, 1996
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- Cellular reservoirs of HIV-1 in the central nervous system of infected individualsAIDS, 1996
- Interaction of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 with a Galactoglycerolipid Associated with Human SpermAIDS Research and Human Retroviruses, 1996
- A sialic acid analogue acting as a receptor determinant for binding but not for infection by influenza C virusFEBS Letters, 1993
- The Galactosyl Ceramide/Sulfatide Receptor Binding Region of HIV-1 gp120 Maps to Amino Acids 206-275AIDS Research and Human Retroviruses, 1993
- Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.Proceedings of the National Academy of Sciences, 1991
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983